Focus on TILs: Prognostic significanceof tumor infiltrating lymphocytes in head and neck cancers

Cancer immunity

James S. Lewis Jr.³  Gavin P. Dunn¹  ,²  Ravindra Uppaluri³ 

[1] Massachusetts General Hospital, HarvardMedical School, Boston, MA, USAMassachusetts General Hospital, HarvardMedical School, Boston, MA, USAMassachusetts General Hospital, HarvardMedical School, Boston, MA, USA;Department of Pathology/Immunology,Washington University School of Medicine, St.Louis, MO, USADepartment of Pathology/Immunology,Washington University School of Medicine, St.Louis, MO, USADepartment of Pathology/Immunology,Washington University School of Medicine, St.Louis, MO, USA;Department of Otolaryngology/Headand Neck Surgery and John Cochran VA Medical Center, WashingtonUniversity School of Medicine, St. Louis,MO, USADepartment of Otolaryngology/Headand Neck Surgery and John Cochran VA Medical Center, WashingtonUniversity School of Medicine, St. Louis,MO, USADepartment of Otolaryngology/Headand Neck Surgery and John Cochran VA Medical Center, WashingtonUniversity School of Medicine, St. Louis,MO, USA

关键词: human;    head andneck cancer;    tumor-infiltrating lymphocytes;    prognosis;    therapy;   

DOI  :  

学科分类：肿瘤学

来源: Cancer immunity

【 授权许可】

Unknown